ASCO Direct™ Highlights Oncology conference held in Seattle to present and discuss the latest findings in cancer research and treatments
The Binaytara Foundation held the ASCO Direct™ Highlights: 2022 Official Annual Meeting Review in Seattle, WA, from June 17-19 to update oncology providers about the latest developments in the management of cancers. This CME-accredited oncology conference was designed to improve the care of cancer patients by educating clinicians involved in cancer care.
There were 197 attendees from fourteen different states at this cancer conference, from Hawaii to New Jersey. Faculty from local institutions and across the country were also in attendance, including well-known experts in the field of hematology and oncology. During the conference, there were twenty-two presentations from faculty and forty-five vendor companies represented.
Here are some highlights from evaluation survey respondents:
“The meeting was great.”
“Excellent conference. I plan to attend again.”
“Fantastic course with great speakers!”
“Wonderful conference – as usual.”
“Great conference – thanks to Dr. Bhatia and Dr. Grivas for leading and asking great questions. Speakers were knowledgeable and approachable for follow up questions. Good variety of topics and both ASCO updates as well as general information that is helpful to those of us in the community taking care of all tumor types. Thank you for a great educational event.”An attendee of the Binaytara Foundation’s ASCO Direct™ Highlights conference on June 18-19, 2022.
“I am happy to help again in the future. Tara and Keegan are super nice,” added volunteer Rudy.
Photos from the conference taken by volunteer photographer Armin Isarian are below.
Future BTF conferences include the 2022 Cellular Therapy Conference in Salt Lake City, UT, Sept 9th-10th, the 2022 Precision Oncology Summit in Salt Lake City, UT, Oct 7th-8th, and the 2022 Seattle Multidisciplinary Thoracic Oncology Conference in Seattle, WA, Oct 22nd. For more information or to register for a conference, please visit education.binayfoundation.org.
About the Binaytara Foundation
The Binaytara Foundation is a global cancer non-profit dedicated to improving access to cancer care in the United States and abroad through education and innovative program models that break down barriers and advance best practices in hematology and oncology. Binaytara Foundation’s major projects include hematology and oncology conferences, and the establishment of a cancer hospital in Nepal.
2022 Summit on Cancer Health Disparities ASCO award Binaytara foundation Binaytara Foundation Cancer Center Binaytara Foundation education academy breast cancer BTF cancer cancer care cancer disparities cancer research cancer treatment cancer treatment in Nepal CME community oncologists conference Conferences continuing education Dr. Binay Shah Dr. Rubina Suwal events Expert Opinion faculty faculty highlight FDA approved Featured head & neck cancer surgery in Nepal healthcare equity hematological malignancies Journal leukemia Lung cancer lymphoma multiple myeloma Nepal Nepal cancer care oncology oncology CME Opinion peer-reviewed journal SCHD upcoming conferences video news Volunteer
By Dr. Inas Abuali Massachusetts General Hospital There is a paucity of available treatment options for patients with advanced papillary renalMore
On March 4, 2023, the U.S. Food and Drug Administration approved expanded use of adjuvant abemaciclib with endocrine therapy for adult patientsMore
On February 9th, 2023, the U.S. Food and Drug Administration approved dostarlimab-gxly for adult patients with recurrent or advanced endometrial cancer (EC)More
Dr. Ghassan Abou-Alfa of Memorial Sloan Kettering Cancer Center shares a recent abstract from ASCO GI, IMBRAVE-151, A Phase II, randomized, double-blindMore
Dr. Daneng Li of City of Hope Comprehensive Cancer Center shares a recent abstract from ASCO GI, NRG/RTOG 1112, a randomized phaseMore